Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.64%
1,047.36
+6.67
+0.64%
—1,040.691,048.261,057.851,043.30——
SIXC
Communications
SIXC
Communications
SIXC
+1.04%
566.19
+5.83
+1.04%
—560.36560.36568.72560.36——
SIXE
Energy
SIXE
Energy
SIXE
-0.47%
1,311.54
-6.15
-0.47%
—1,317.691,324.291,335.361,309.90——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.36%
1,585.09
-21.82
-1.36%
—1,606.911,611.511,621.751,583.36——
SIXM
Financials
SIXM
Financials
SIXM
+1.23%
597.55
+7.27
+1.23%
—590.28592.25601.18592.25——
SIXR
Staples
SIXR
Staples
SIXR
+0.46%
831.77
+3.79
+0.46%
—827.98828.20835.94826.74——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.83%
198.68
+1.64
+0.83%
—197.04197.04200.54197.04——
SIXT
Technology
SIXT
Technology
SIXT
-1.72%
2,573.07
-45.13
-1.72%
—2,618.202,638.492,649.452,569.91——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.86%
932.59
+7.93
+0.86%
—924.66929.51938.99929.51——
SIXV
Health care
SIXV
Health care
SIXV
+0.47%
1,456.35
+6.76
+0.47%
—1,449.591,453.441,462.731,452.88——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.18%
2,140.72
+3.83
+0.18%
—2,136.892,149.922,166.642,139.01——
BMRN:NASDAQ
Biomarin Pharmaceutical Inc
$54.70
+1.03%
(+0.56) 1D
Mar 30, 2:27:28 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BMRN...
Open
$54.42
High
$55.00
Low
$53.94
Mkt. cap
10.52B
Avg. vol.
2.22M
Volume
418.90K
P/E ratio
30.31
52-wk high
$71.28
52-wk low
$50.76
EPS
$1.80
Beta
0.25
Shares outstanding
192.32M
No. of employees
3K
News stories
From sources across the web
Profile
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials. Wikipedia
About Biomarin Pharmaceutical Inc
CEOAlexander Hardy
Employees3.22K
FoundedMar 1997
HeadquartersSan Rafael, California, United States
SectorBiotechnology
Websitebiomarin.com
Last report
Feb 23, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
0.46/ (0.56 est.)USD
-17.94%miss
Revenue / Estimate
874.56M/ (835.03M est.)USD
+4.73%beat
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
745.14M
825.41M
776.13M
874.56M
Cost of goods sold
310.29M
311.40M
549.56M
348.91M
Cost of revenue
310.29M
311.40M
549.56M
348.91M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
206.12M
232.28M
268.42M
324.16M
Operating expense
210.96M
237.12M
273.26M
329.01M
Total operating expenses
521.25M
548.52M
822.82M
677.92M
Operating income
223.89M
276.89M
-46.69M
196.64M
Other non operating income
-1.95M
4.83M
5.09M
1.02M
EBT including unusual items
238.09M
297.87M
-26.32M
-27.15M
EBT excluding unusual items
238.09M
297.87M
-26.32M
214.10M
Income tax expense
52.40M
57.34M
4.42M
19.42M
Effective tax rate
22.01%
19.25%
-16.79%
-71.52%
Other operating expenses
-
-
-
-
Net income
185.69M
240.53M
-30.74M
-46.57M
Net profit margin
24.92%
29.14%
-3.96%
-5.33%
Earnings per share
1.13
1.44
0.12
0.46
Interest and investment income
19.01M
18.83M
17.85M
19.21M
Interest expense
-2.86M
-2.68M
-2.58M
-2.78M
Net interest expenses
16.15M
16.15M
15.28M
16.43M
Depreciation and amortization charges
-
-
-
-
EBITDA
245.96M
295.45M
-28.20M
209.68M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer